Does the thrifty phenotype result from chronic glutamate intoxication? A hypothesis

Verfasser / Beitragende:
[M. Hermanussen, J. A. F. Tresguerres]
Ort, Verlag, Jahr:
2003
Enthalten in:
Journal of Perinatal Medicine, 31/6(2003-11-20), 489-495
Format:
Artikel (online)
ID: 378850997
LEADER caa a22 4500
001 378850997
003 CHVBK
005 20180305123323.0
007 cr unu---uuuuu
008 161128e20031120xx s 000 0 eng
024 7 0 |a 10.1515/JPM.2003.075  |2 doi 
035 |a (NATIONALLICENCE)gruyter-10.1515/JPM.2003.075 
245 0 0 |a Does the thrifty phenotype result from chronic glutamate intoxication? A hypothesis  |h [Elektronische Daten]  |c [M. Hermanussen, J. A. F. Tresguerres] 
520 3 |a The thrifty phenotype hypothesis proposes that the epidemiological associations between poor fetal and infant growth and the subsequent development of the metabolic syndrome, result from the effects of poor nutrition in early life. The present review however, considers an opposite explanation. We hypothesize that fetal over-nutrition plays a major role in the development of the metabolic syndrome. We found evidence that the thrifty phenotype may be the consequence of fetal hyperglutamatemia. Maternal glutamate (GLU) reaches the fetal circulation, as part of the materno-fetal glutamine-glutamate exchange. Glutamine is absorbed from the maternal circulation, and deaminated for nitrogen utilization, resulting in a fetal production of GLU. GLU is extracted as it returns to the placenta. When the umbilical plasma flow is low, GLU may be trapped in the fetal circulation, and reaches neurotoxic levels. Administering GLU to newborn rodents completely destructs arcuate nucleus neurons, and results in permanently elevated plasma leptin levels that fail to adequately counter-regulate food intake. Chronic fetal exposure to elevated levels of GLU may be caused by chronic maternal over-nutrition or by reduced umbilical plasma flow. We strongly suggest abandoning the flavoring agent monosodium glutamate and reconsidering the recommended daily allowances of protein and amino acids during pregnancy. 
540 |a Copyright © 2003 by Walter de Gruyter GmbH & Co. KG 
690 7 |a Human reproduction, growth & development  |2 nationallicence 
690 7 |a Gynaecology & obstetrics  |2 nationallicence 
690 7 |a Paediatric medicine  |2 nationallicence 
700 1 |a Hermanussen  |D M.  |4 aut 
700 1 |a Tresguerres  |D J. A. F.  |4 aut 
773 0 |t Journal of Perinatal Medicine  |d Walter de Gruyter  |g 31/6(2003-11-20), 489-495  |x 0300-5577  |q 31:6<489  |1 2003  |2 31  |o jpme 
856 4 0 |u https://doi.org/10.1515/JPM.2003.075  |q text/html  |z Onlinezugriff via DOI 
908 |D 1  |a research article  |2 jats 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1515/JPM.2003.075  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Hermanussen  |D M.  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Tresguerres  |D J. A. F.  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Journal of Perinatal Medicine  |d Walter de Gruyter  |g 31/6(2003-11-20), 489-495  |x 0300-5577  |q 31:6<489  |1 2003  |2 31  |o jpme 
900 7 |b CC0  |u http://creativecommons.org/publicdomain/zero/1.0  |2 nationallicence 
898 |a BK010053  |b XK010053  |c XK010000 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-gruyter